Literature DB >> 7074833

Monitoring octanoic and decanoic acids in plasma from children with intractable epilepsy treated with medium-chain triglyceride diet.

D Haidukewych, W I Forsythe, M Sills.   

Abstract

We describe a procedure for gas-chromatographic determination of n-octanoic and n-decanoic acids in 100 microL of plasma from children with intractable epilepsy treated with medium-chain triglyceride (MCT) diet. With n-nonanoic acid as the internal standard, the extraction efficiencies for octanoic and decanoic acids were 98 and 105%, respectively. Within-run CVs for octanoic acid at 0.5, 1.0, 2.5, 5.0, 7.5, and 10.0 micrograms/0.1 mL were 8.8, 7.9, 8.5, 6.5, 4.3, and 5.7%, respectively. For decanoic acid at identical concentrations, the CVs were 10.0, 7.4, 4.9, 4.0, 2.6, and 3.5%, respectively. For 10 children on MCT diet (45.9% of calories supplied as MCT) the mean concentrations of octanoic and decanoic acids were 44.2 and 27.0 mg/L, respectively. Presence of relatively "high" quantities of these acids in plasma may contribute to seizure control when MCT diet is prescribed for intractable childhood epilepsy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7074833

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  21 in total

1.  Tridecanoin is anticonvulsant, antioxidant, and improves mitochondrial function.

Authors:  Kah Ni Tan; Catalina Carrasco-Pozo; Tanya S McDonald; Michelle Puchowicz; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

2.  Caprylic acid and glyceryl trinitrate combination for eradication of biofilm.

Authors:  Joel Rosenblatt; Ruth A Reitzel; Issam Raad
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

Review 3.  Alternative Fuels in Epilepsy and Amyotrophic Lateral Sclerosis.

Authors:  Tesfaye W Tefera; Kah Ni Tan; Tanya S McDonald; Karin Borges
Journal:  Neurochem Res       Date:  2016-11-21       Impact factor: 3.996

4.  Oral Palatability Testing of a Medium-Chain Triglyceride Oil Supplement (MCT) in a Cohort of Healthy Dogs in a Non-Clinical Setting.

Authors:  Benjamin Andreas Berk; Rowena Mary-Anne Packer; Julia Fritz; Holger Andreas Volk
Journal:  Animals (Basel)       Date:  2022-06-26       Impact factor: 3.231

5.  Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids.

Authors:  Kelly L Gorres; Derek Daigle; Sudharshan Mohanram; George Miller
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

Review 6.  Ketogenic diet, neuroprotection, and antiepileptogenesis.

Authors:  Madhuvika Murugan; Detlev Boison
Journal:  Epilepsy Res       Date:  2020-08-19       Impact factor: 3.045

7.  Role of octanoic and decanoic acids in the control of seizures.

Authors:  M A Sills; W I Forsythe; D Haidukewych
Journal:  Arch Dis Child       Date:  1986-12       Impact factor: 3.791

8.  A ketogenic diet protects DBA/1 and Scn1aR1407X/+ mice against seizure-induced respiratory arrest independent of ketosis.

Authors:  Megan S Crotts; YuJaung Kim; Eduardo Bravo; George B Richerson; Frida A Teran
Journal:  Epilepsy Behav       Date:  2021-09-29       Impact factor: 2.937

9.  The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome.

Authors:  Marta Kanabus; Elisa Fassone; Sean David Hughes; Sara Farahi Bilooei; Tricia Rutherford; Maura O' Donnell; Simon J R Heales; Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2016-04-14       Impact factor: 4.982

10.  Seizure control by ketogenic diet-associated medium chain fatty acids.

Authors:  Pishan Chang; Nicole Terbach; Nick Plant; Philip E Chen; Matthew C Walker; Robin S B Williams
Journal:  Neuropharmacology       Date:  2012-11-20       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.